AlphAIAlphAI — Financial news for AI agents
investing.comSEP 32 min read$NVST

Envista Holdings stock rises on JPMorgan upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded them to Overweight with a $32 price target, up from $29. Analyst Lilia-Celine B Lozada cited improved execution, durable growth, and valuation not reflecting fundamentals. The upgrade comes ahead of the company's Investor Day on September 17.

Original reporting
investing.com
Published Sep 3, 2026, 12:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$NVST
Bullish
high confidence
Mentioned
$NVST
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NVSTBullishMed
01

Why it matters

The upgrade could attract short‑term buying and set a higher valuation baseline ahead of the Investor Day.

02

Market read

The upgrade is a fresh catalyst that may drive NVST price action ahead of its Investor Day.

03

What to watch

Potential supply‑chain constraints and competitive pressure from larger dental device makers.

Relevance 7/10Novelty 8/10Timing: premarket today

Background

Envista Holdings (NVST) is a dental device maker; the upgrade comes ahead of its Investor Day on Sept. 17.

Company-level read

Ticker impact

$NVSTBullishHigh confidence
Context

JPMorgan upgraded Envista Holdings to Overweight with a new $32 price target, prompting a 2.3% pre‑market rise.

Expected impact

Potential upside of 5‑10% over the next weeks if the upgrade drives buying pressure.

Evidence & confidence

The upgrade includes a higher price target and a bullish growth thesis, which historically moves mid‑cap med‑tech stocks.

Market effects

Sector

May lift other med‑tech and dental implant stocks as investors reassess growth prospects.

Regional

Limited to U.S. listed med‑tech sector; no broad regional effect.

Global

Minor global impact; primarily U.S. equity market relevance.

Counterpoint

What could challenge this read

The upgrade may be premature if macro‑discretionary demand weakens, risking a pull‑back.

Key entities

  • Analyst
    JPMorgan

    Provided the upgrade to Overweight with a $32 price target.

  • Company
    Envista Holdings Corp.

    Dental device manufacturer whose shares rose on the upgrade.

Read at source← All news

Also covered by

2 outlets

Related articles

SEP 10
$NVSTMed

BMO reiterates Envista stock rating ahead of investor day

BMO Capital reiterated a Market Perform rating on Envista Holdings (NYSE:NVST) with a $29.00 price target, noting potential upside. The company showed 11.89% revenue growth over the last year, and 11 analysts revised earnings upwards. Envista recently beat Q2 2026 earnings and revenue estimates, raising its full-year outlook. JPMorgan upgraded the stock to Overweight with a $32.00 target, while Mizuho maintained a Neutral rating.

investing.com2 min
SEP 4
$NVSTHigh

Envista Holdings Shares Rise After JPMorgan Upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded it to Overweight, raising the price target to $32 from $29. The upgrade comes ahead of Envista's Investor Day on September 17, with JPMorgan expecting improved execution and growth. The analyst anticipates a medium-term core growth range of 2.5% to 4.5%, citing resilient demand despite macroeconomic uncertainty.

yahoo.com2 min
SEP 3
$NVSTHigh

Why is Envista stock rallying today?

Envista (NVST) stock rose 2.3% pre-market after JPMorgan upgraded it to Overweight, raising its price target to $32. The bank cited improved execution, resilient demand, and attractive valuation. Envista's Q2 2026 results beat estimates, with adjusted EPS of $0.41 and revenue of $730.5M. The upgrade is ahead of the company's Investor Day on September 17.

investing.com1 min
AUG 14
$NVSTHighAI 9/10

Envista (NVST) Q2 2026 Earnings Call Transcript

Envista (NVST) reported Q2 2026 results on an earnings call, citing 5% core growth and sales of $731 million. Adjusted gross margin rose to 55.1%, adjusted EBITDA grew 28% with 14.7% margin, and adjusted EPS was $0.41 (+58%). Free cash flow was $105 million. The company raised 2026 guidance: core growth 3.5% to 4.5%, adjusted EBITDA 11% to 14%, adjusted EPS $1.50 to $1.55.

yahoo.com12 min
AUG 5
$NVSTHigh

Envista Reports Second Quarter 2026 Results

Envista Holdings Corp (NVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Envista Reports Second Quarter 2026 Results BREA, Calif., August 5, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026. “We built on our fast start in Q1 with continued good performance in Q2,”

SEC EDGAR 8-K6 min